???global.info.a_carregar???
Diogo Almeida is currently pursuing his PhD in Pharmacy at the University of Lisbon, with a specialization in Pharmacoepidemiology. His research is dedicated to applying Real-World Data (RWD) and Patient Experience Data (PED) in regulatory and health technology assessment frameworks. Diogo is particularly interested in how these data can inform and improve decision-making processes, ultimately contributing to more effective evidence-based and patient-focused healthcare solutions.
Identification

Personal identification

Full name
Diogo Almeida

Citation names

  • Almeida, Diogo

Author identifiers

Ciência ID
961D-6623-6B99
ORCID iD
0009-0004-5648-2800

Addresses

  • Avenida Professor Gama Pinto, 1649-003, Lisboa, Lisboa, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
  • Medical and Health Sciences - Health Sciences - Epidemiology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2023/10 - 2027
Ongoing
 Farmácia (Doutoramento)
Major in Farmacoepidemiologia
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Unlocking Real-World Data's Potential in Patient-Centered Medicines Regulation and Health Technology Assessment Decision-Making" (THESIS/DISSERTATION)
2018/09 - 2023/07
Concluded
 Ciências Farmacêuticas (Mestrado integrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An interrupted time-series analysis" (THESIS/DISSERTATION)
Projects

Contract

Designation Funders
2023/11 - 2027 More-EUROPA – ‘More Effectively Using Registries to SuppOrt PAtient-Centered Regulatory and HTA Decision-Making
HORIZON-HLTH-2022-TOOL-11-02
PhD Student Fellow
Outputs

Publications

Conference poster
  1. Jorge Monteiro; Almeida, Diogo; João Paulo Fernandes; Sepodes, Bruno; Torre, Carla. "Review of studies evaluating effectiveness of risk minimisation measures for oncology medicinal products registered in the European Medicines Agency (HMA-EMA) Catalogue: findings and lessons learned". Paper presented in Dia da Farmacovigilância 2024 - Farmacovigilância: Rumo a uma Abordagem Integrada, 2024.
  2. Almeida, Diogo; António Teixeira Rodrigues; Jose Pedro Guerreiro; Ewa Balkowiec-Iskra; Robert Vander Stichele; Sepodes, Bruno; Torre, Carla. "COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An interrupted time-series analysis". Paper presented in 7th International Conference on Phthiraptera (ICP 7), 2023.
Journal article
  1. Diana Mandslay; Diogo Almeida; Adriana Marques; Joao Rocha; Frantisek Drafi; Bruno Sepodes; Carla de Matos Torre. "Comparative Analysis of Post-Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023". Clinical Pharmacology & Therapeutics (2024): http://dx.doi.org/10.1002/cpt.3410.
    10.1002/cpt.3410
  2. Edna Ribeiro Parracha; António Teixeira Rodrigues; Sofia Oliveira-Martins; Sónia Romano; Diogo Almeida; Bruno Sepodes; Carla de Matos Torre. "Pharmacist's role in influenza immunisation: a scoping review". Journal of Pharmacy Practice and Research (2024): http://dx.doi.org/10.1002/jppr.1932.
    10.1002/jppr.1932
  3. Diogo Almeida; Antonio Teixeira Rodrigues; Jose Pedro Guerreiro; Ewa Balkowiec-Iskra; Robert Vander Stichele; Bruno Sepodes; Carla Torre. "COVID-19 pandemic and the consumption of self-care products for pediculosis capitis in Portugal: an interrupted time-series analysis". Parasitology Research (2024): http://dx.doi.org/10.1007/s00436-024-08258-2.
    10.1007/s00436-024-08258-2
  4. Diogo Almeida; Denise Umuhire; Rosa Gonzalez-Quevedo; Ana António; Juan Garcia Burgos; Patrice Verpillat; Nathalie Bere; Bruno Sepodes; Carla Torre. "Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU". Frontiers in Medicine (2024): http://dx.doi.org/10.3389/fmed.2024.1408636.
    10.3389/fmed.2024.1408636
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/02/07 COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An interrupted time-series analysis 54th Meeting of the Portuguese Society of Pharmacology
Portuguese Society of Pharmacology (Lisbon, Portugal)

Association member

Society Organization name Role
2024/02/07 - Current Sociedade Portuguesa de Farmacologia (Portuguese Society of Pharmacology) Member
2024/02 - Current Associação Portuguesa de Jovens Farmacêuticos (Portuguese Association of Young Pharmacists) Board Member
2023/11 - Current Ordem dos Farmacêuticos (Portuguese Pharmaceutical Society) Member

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2022/10 - 2023/09 Evaluation of a Master’s Degree in Pharmaceutical Sciences from a Portuguese University.
Evaluator
 Agência De Avaliação e Acreditação do Ensino Superior, Portugal